Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Arcellx Inc (ACLX)
Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,737,127
  • Shares Outstanding, K 48,686
  • Annual Sales, $ 0 K
  • Annual Income, $ -188,680 K
  • 60-Month Beta 0.03
  • Price/Sales 55.81
  • Price/Cash Flow N/A
  • Price/Book 10.52
Trade ACLX with:

Options Overview Details

View History
  • Implied Volatility 79.74% ( -10.13%)
  • Historical Volatility 74.97%
  • IV Percentile 43%
  • IV Rank 41.97%
  • IV High 111.63% on 12/27/22
  • IV Low 56.67% on 09/13/23
  • Put/Call Vol Ratio 0.44
  • Today's Volume 2,986
  • Volume Avg (30-Day) 493
  • Put/Call OI Ratio 1.24
  • Today's Open Interest 6,228
  • Open Int (30-Day) 4,020

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.63
  • Number of Estimates 6
  • High Estimate -0.32
  • Low Estimate -1.10
  • Prior Year -0.76
  • Growth Rate Est. (year over year) +17.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.83 +19.46%
on 11/13/23
59.08 -11.38%
on 12/08/23
+6.85 (+15.05%)
since 11/10/23
3-Month
30.88 +69.56%
on 10/27/23
59.08 -11.38%
on 12/08/23
+16.67 (+46.71%)
since 09/11/23
52-Week
25.59 +104.61%
on 12/12/22
59.08 -11.38%
on 12/08/23
+24.34 (+86.87%)
since 12/09/22

Most Recent Stories

More News
Chart of the Day: Arcellx - Reimagining Cell Therapy

The Chart of the Day belongs to the immunotherapy company Arcellx (ACLX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest...

ACLX : 52.36 (-6.87%)
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 52.36 (-6.87%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 52.36 (-6.87%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 52.36 (-6.87%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 52.36 (-6.87%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 52.36 (-6.87%)
Stocks End Moderately Lower Ahead of Powell’s Testimony to Congress

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.72%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 4,622.44 (+0.39%)
SPY : 461.99 (+0.39%)
$DOWI : 36,404.93 (+0.43%)
DIA : 364.69 (+0.43%)
$IUXX : 16,221.73 (+0.85%)
QQQ : 395.52 (+0.85%)
HAL : 34.77 (-0.46%)
DVN : 44.41 (+0.73%)
PSX : 126.41 (+0.87%)
APA : 34.70 (+0.67%)
CVX : 144.35 (+0.03%)
COP : 112.16 (+0.08%)
Stocks Fall on Chinese Economic Concerns and Wariness Ahead of Fed Chair Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.73%....

$SPX : 4,622.44 (+0.39%)
SPY : 461.99 (+0.39%)
$DOWI : 36,404.93 (+0.43%)
DIA : 364.69 (+0.43%)
$IUXX : 16,221.73 (+0.85%)
QQQ : 395.52 (+0.85%)
APA : 34.70 (+0.67%)
HAL : 34.77 (-0.46%)
DVN : 44.41 (+0.73%)
MRO : 24.05 (-0.17%)
VLO : 123.48 (+0.60%)
CVX : 144.35 (+0.03%)
Markets Today: Stocks Slip on China Economic Concerns and Higher Bond Yields

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.33%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.28%. U.S. stock index futures this morning are moderately...

ESZ23 : 4,626.00s (+0.40%)
NQZ23 : 16,237.00s (+0.86%)
NKE : 118.61 (+2.33%)
PDD : 143.01 (+2.91%)
JD : 25.60 (-3.21%)
BABA : 71.37 (-1.07%)
NTES : 105.02 (+0.46%)
SOFI : 8.07 (-0.74%)
AMAT : 155.14 (+5.02%)
ACLX : 52.36 (-6.87%)
WBD : 11.43 (-0.35%)
DICE : 47.55 (+0.06%)
Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 52.36 (-6.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

See More

Key Turning Points

3rd Resistance Point 61.03
2nd Resistance Point 60.06
1st Resistance Point 58.14
Last Price 52.36
1st Support Level 55.24
2nd Support Level 54.27
3rd Support Level 52.35

See More

52-Week High 59.08
Last Price 52.36
Fibonacci 61.8% 46.29
Fibonacci 50% 42.34
Fibonacci 38.2% 38.39
52-Week Low 25.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar